Genzyme Corp. is in a dispute with Abbott Laboratories over the percentage of infringing product that was supplied by the Company.
The Company said that it may in the future…
Becton Dickinson and Co. is facing Retractable Technologies Inc.’s suit in the U.S. District Court for the Eastern District of Texas, alleging that the Company’s Integra TM syringes infringe a…
The U.S. District Court for the Eastern District of Texas has scheduled to commence trial on Retractable Technologies Inc.’s patent claims against Becton Dickinson & Co. in March 2009.
RTI filed…
The jury in Therasense, Inc.’s patent infringement suit, on Aug. 8, 2008, ruled in favor of Becton, Dickinson and Co. and determined that Abbott Laboratories’ patent is not valid.
On May…
Zimmer Holdings Inc.’s motion for summary judgment on the invalidity of certain claims of Howmedica Osteonics Corp.’s U.S. Patent No. 6,818,020 remains pending in the U.S. District Court for the…
Wyeth and its licensing partner, Nycomed GmbH, are pursuing a lawsuit against Sandoz Inc. in the U.S. District Court for the Northern District of Illinois, alleging infringement of U.S. Patent…
Wyeth pursues a lawsuit against Sandoz Inc. in the U.S. District Court for the District of Delaware, alleging that Sandoz’s filing of Abbreviated New Drug Application with the U.S. Food…
The U.S. District Court for the Central District of California has ruled to extend for at least 90 days the September 2008 trial date in Wyeth’s patent infringement litigation against…
The REFACTO patent infringement litigation initiated by a subsidiary of Wyeth against Novartis Vaccines and Diagnostics, Inc. remains pending in the U.S. District Court for the District of Delaware.
On May…
Wyeth and its licensing partner, Nycomed GmbH, anticipate a trial for the Company’s PROTONIX patent infringement litigation in the U.S. District Court for the District of New Jersey will occur…